Singapore’s Clearbridge Health adjusts conversion price of notes

Chicago, Aug. 1 – Clearbridge Health Ltd. said that the conversion price for its convertible bonds will be shifted lower to S$0.14 from S$0.28.

The downward adjustment in the conversion price is due to the announced proposed placement of 80,450,200 new ordinary shares at a price of S$0.141 each, according to a company notice.

The adjusted conversion price will be effective from the date of issue of the new placement shares.

The medical laboratory company is based in Singapore.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.